 DEFINITION: It includes all fibers that can influence the motor end plate activity and do not pass in the pyramidal tract.

Slides:



Advertisements
Similar presentations
Extrapyramidal disorder and movement disorder
Advertisements

University of Sulaimaniah
Cortically OriginatedMovement Cortically Originated Movement I. Motor Tract (corticospinal tractus) Extrapyramidal System (basal ganglia) Cerebellum Praxis.
GAIT DISTURBANCES Anshul Jain.
Chapter 13: Brainstem and Basal Ganglia
Parkinson’s Disease (PD)
An Overview of Conventional and Experimental Treatments
Idiopathic parkinson’s disease (IPD)
Basal Ganglia: PATHOLOGIES Emma & Amrit. PARKINSON’S HUNTONGTON’S BALISMUS/HEMIBALISMUS ATHETOSIS WILSON’S DISEASE.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Movement part 2. Cerebellum and Brainstem KW p. 363.
Brain Control of Movement. Motor Control Hierarchy  High level – plans and executes strategy Association areas of cortex Basal ganglia gives the “go”
Drugs Used to Treat Parkinson’s Disease By Jasmine and Morgan 11/13/03.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Basal ganglia & cerebellar pathology
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
Pyramidal and extrapyramidal tracts
Parkinson’s Disease By Devin Cornford
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Antiparkinsonian Drugs.
Some Terminologies White matter : myelinated fibre tracts White matter : myelinated fibre tracts Gray matter : areas of neuronal cell bodies Gray matter.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 14 Antiparkinsonian Drugs.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Disease superKAT :).
Brainstem and Basal Ganglia
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Nervous system Ⅳ Wei yuanyuan. Control of motor function  Spinal cord  Brain stem  Cerebellum  Cerebral cortex.
2217 – Motor system Somatic – striated muscle Autonomic – smooth muscle, cardiac muscle, glands Upper and lower motor neurons (final common path) Segmental.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Basal Nuclei Or Basal ganglia By Dr.Musaed Al-Fayez.
MOTOR THE WORD MOTOR MEANS M O V E M E N T MOTOR SYSTEM INCLUDES MOTOR CORTEX PYRAMIDAL TRACTS CORTICO SPINAL CORTICO BULBAR EXTRA PYRAMIDAL TRACTS BASAL.
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
Brain Motor Control Lesson 20. Hierarchical Control of Movement n Association cortices & Basal Ganglia l strategy : goals & planning l based on integration.
Parkinson’s Disease Dr. Andrew Schmelz, PharmD Post-Doctoral Teaching Fellow Dept of Pharmacy Practice Purdue University March 4, 2009.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
Movement disorders Dr.Zana A. Mohammed M.B.Ch.B, F.I.B.M.S. NEUROLOGY
PARKINSON’S DISEASE.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 14 Antiparkinsonian Drugs.
Extrapyramidal pathway
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
CNS -Antiparkinsonian Drugs Discuss the signs and symptoms exhibited by a patient with Parkinson’s Disease Describe the actions and intended effects of.
Pathogenesis and pathology of parkinsonism
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Brain Mechanisms of Movement Lecture 19. Hierarchical Control of Movement n Association cortices & Basal Ganglia l strategy : goals & planning l based.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
CNS-IV.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
PARKINSON’S DISEASE CHAMINDA UNANTENNE RN,MS,MSN.
Basal ganglia D.Nimer D.Rania Gabr D.Safaa D.Elsherbiny.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
Direct motor pathway Corticospinal pathway.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
Parkinson Disease Parkinson disease is an idiopathic, slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity),
MOVEMENT DISORDERS.
Dr. Farah Nabil Abbas MBChB, MSc, PhD
Drugs of Anti-Parkinson’s disease
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
The Approach to Tremor (with case examples) Praveen Dayalu MD Associate Professor Department of Neurology University of Michigan.
Introduction to movement disorders and parkinsonism
Parkinsonism and Anesthesia
The cerebellum:.
Basal ganglia It is a collection of grey matter deeply in each
Classification of Epilepsy (p. 227)
Neurodegenerative diseases
FUNCTIONS OF THE BASAL NUCLEI FUNCTIONS OF THE BASAL NUCLEI assist in the regulation of voluntary movement & the learning of motor skills initiate movement.
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

 DEFINITION: It includes all fibers that can influence the motor end plate activity and do not pass in the pyramidal tract.

 Functions of the Extrapyramidal system: 1-Regulation and integration of voluntary motor activity. 2-Regulation and maintenance of the muscle tone. 3-Regulation and maintenance of emotional and associative movements.

 Disturbance of the functions of the extra- pyramidal system leads to:

II-Disturbance in the regulation and maintenance of normal muscle tone resulting in: III-Disturbance in the regulation and maintenance of emotional and associated movements resulting in:

 It is due to deficiency of dopamine in the basal ganglia and substantia nigra.

*- Causes : I- Idiopathic: Parkinson's disease (paralysis agitans). The cause is unknown.

II- Symptomatic: There is a known cause which leads to deficiency of dopamine in the brain,but without structural changes in the substantia nigra or basal ganglia.

1- Inflammatory: 2- Vascular: 3- Toxic: 4- Neoplastic: 5- Traumatic:

I-Tremors:-

Mask-Face -Bent Posture- Gorilla like Pill- rolling Short steppage – Shuffling gait Parkinson’s patient

II- Rigidity :-

III-Loss of emotional and associative movements: - - IV-Other clinical manifestations may be found in some cases (mainly post-encephalitic):

* By far the commonest causes of Parkinsonism are: 1) Paralysis agitans. 2) Post-encephalitic. 3) Atherosclerosis.

- The manifestations of Parkinsonism are due to an imbalance between the levels of acetylcholine and dopamine in the basal ganglia and substantia nigra.

I- Anticholinergic drugs:.

II-Levo-Dopa: (Dopamine precursor):

III_Levo-Dopa + Carbi-Dopa: (Sinemet)

* On and off phenomenon: After long term treatment with L-dopa the patient may show signs a Parkinsonism (under treatment) alternating rapidly with signs of drug overdosage, mainly Chorea (over treatment),as if being turned "on and off." The dose of L-dopa should be reduced and other drugs as Bromocriptine are given.

III-Dopamine agonist- IV-Amantadine hydrochloride (Symmetrel): V- Surgical : 1) Pallidectomy or 2) Thalamotomy

 DEFINITION: Chorea is involuntary, static, irregular, dysrhythmic, sudden, jerky, pseudopurposive movements of any part of the body, including the face, trunk and/or limbs.

 This a condition where there are: * Involuntary, irregular, static, slow, snake-like movements. They involve the extremities (especially the hands & fingers) and the face on each side.

* This is a condition where there are: * Involuntary, static, very slow, torsion or twisting like movements. * They involve the neck, trunk & the proximal muscles of the extremities

Thank you